257 related articles for article (PubMed ID: 30231891)
1. Characteristics of patients with thromboembolic disorders on warfarin therapy in resource limited settings.
Kamuren Z; Kigen G; Keter A; Maritim A
BMC Health Serv Res; 2018 Sep; 18(1):723. PubMed ID: 30231891
[TBL] [Abstract][Full Text] [Related]
2. Out-of-range international normalized ratio values and healthcare cost among new warfarin patients with non-valvular atrial fibrillation.
Nelson WW; Wang L; Baser O; Damaraju CV; Schein JR
J Med Econ; 2015 May; 18(5):333-40. PubMed ID: 25549062
[TBL] [Abstract][Full Text] [Related]
3. International normalized ratio stabilization in newly initiated warfarin patients with nonvalvular atrial fibrillation.
Nelson WW; Desai S; Damaraju CV; Lu L; Fields LE; Wildgoose P; Schein JR
Curr Med Res Opin; 2014 Dec; 30(12):2437-42. PubMed ID: 25170587
[TBL] [Abstract][Full Text] [Related]
4. International normalized ratio stability in warfarin-experienced patients with nonvalvular atrial fibrillation.
Nelson WW; Desai S; Damaraju CV; Lu L; Fields LE; Wildgoose P; Schein JR
Am J Cardiovasc Drugs; 2015 Jun; 15(3):205-11. PubMed ID: 25944648
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England.
Abohelaika S; Kamali F; Avery P; Robinson B; Kesteven P; Wynne H
Age Ageing; 2014 Sep; 43(5):708-11. PubMed ID: 24947831
[TBL] [Abstract][Full Text] [Related]
6. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
Agarwal S; Bennett D; Smith DJ
Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
[TBL] [Abstract][Full Text] [Related]
7. How well does the target INR level maintain in warfarin-treated patients with non-valvular atrial fibrillation?
Kim JH; Song YB; Shin DH; Kim JS; Choi JO; On YK; Kim JS
Yonsei Med J; 2009 Feb; 50(1):83-8. PubMed ID: 19259353
[TBL] [Abstract][Full Text] [Related]
8. Majority of Total Joint Arthroplasties Are Subtherapeutic on Warfarin at Time of Discharge: Another Reason to Avoid Warfarin as a Venous Thromboembolism Prophylaxis?
Rondon AJ; Goswami K; Tan TL; Shohat N; Parvizi J
J Arthroplasty; 2018 Sep; 33(9):2787-2791. PubMed ID: 29871833
[TBL] [Abstract][Full Text] [Related]
9. Attainment of Target in Therapeutic Range of International Normalized Ratio and Correlates Among Patients on Warfarin Therapy at Jimma Medical Center, Jimma, Ethiopia.
Jada AU; Disassa GM; Melesse BH; Abafogi MM; Abera EG; Jibicho KH; Tukeni KN
Clin Ther; 2024 Apr; 46(4):354-359. PubMed ID: 38429119
[TBL] [Abstract][Full Text] [Related]
10. [INTERNATIONAL NORMALIZED RATIO VALUES AND HEMORRHAGE IN HOSPITALIZED PATIENTS STARTING WARFARIN THERPY: AN OBSERVATIONAL STUDY].
Abadi U; Ellis MH
Harefuah; 2015 Aug; 154(8):490-3, 541-2. PubMed ID: 26480611
[TBL] [Abstract][Full Text] [Related]
11. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
[TBL] [Abstract][Full Text] [Related]
12. Warfarin for non-rheumatic atrial fibrillation: five year experience in a district general hospital.
Yousef ZR; Tandy SC; Tudor V; Jishi F; Trent RJ; Watson DK; Cowell RP
Heart; 2004 Nov; 90(11):1259-62. PubMed ID: 15486116
[TBL] [Abstract][Full Text] [Related]
13. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
Hirano T; Kaneko H; Mishina S; Wang F; Morita S
J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
[TBL] [Abstract][Full Text] [Related]
14. Patterns of international normalized ratio values among new warfarin patients with nonvalvular atrial fibrillation.
Nelson WW; Milentijevic D; Wang L; Baser O; Damaraju CV; Schein JR
Blood Coagul Fibrinolysis; 2016 Dec; 27(8):899-906. PubMed ID: 26886362
[TBL] [Abstract][Full Text] [Related]
15. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
[TBL] [Abstract][Full Text] [Related]
16. A prospective, multi-center cohort study: investigating the ability of warfarin-treated patients to predict their INR.
McNamara K; Witry M; Bryant G; Koenigsfeld C; Lehman N; Logemann C; Mormann M; Rueber A; Herring M; Hoehns JD
Clin Res Cardiol; 2019 Feb; 108(2):212-217. PubMed ID: 30091085
[TBL] [Abstract][Full Text] [Related]
17. International Normalized Ratio Variability: A Measure of Anticoagulation Quality or a Powerful Mortality Predictor.
Vanerio G
J Stroke Cerebrovasc Dis; 2015 Oct; 24(10):2223-8. PubMed ID: 26232891
[TBL] [Abstract][Full Text] [Related]
18. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.
Anthony CJ; Karim S; Ackroyd-Stolarz S; Fry A; Murphy NG; Christie R; Zed PJ
Ann Pharmacother; 2011 Jul; 45(7-8):881-7. PubMed ID: 21750309
[TBL] [Abstract][Full Text] [Related]
19. Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control.
Morgan CL; McEwan P; Tukiendorf A; Robinson PA; Clemens A; Plumb JM
Thromb Res; 2009 May; 124(1):37-41. PubMed ID: 19062079
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
